Veracyte's substantial beat on EPS estimates and year-over-year revenue growth are strong indicators of the company's financial health and operational efficiency. Historically, earnings beats have been followed by share price movements, although the company experienced a drop after the last quarter's beat. The positive earnings report could lead to short-term bullish sentiment among investors, despite past post-earnings share price volatility.